![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif)
Practice Commentary
Bruce G. Pollock, MD, PhD
Arch Fam Med. 1996;5(7):412.
References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Pollock BG. Recent developments in drug metabolism of relevance to psychiatrists. Harvard Rev Psychiatry. 1994;2:204-213.
PUBMED
2. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 1996;153:311-320.
FREE FULL TEXT
3. Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol. 1995;15:387-398.
PUBMED
4. Swims MP. Potential terfenadine-fluoxetine interaction. Ann Pharmacother 1993;27:1404-1405.
PUBMED
5. Rosenblatt JE, Rosenblatt NC. Sertraline-terfenadine interaction? Curr Affect Illness. 1996;15:14.
6. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA. 1993;269:1513-1518.
FREE FULL TEXT
|